Fustibal Overview

  • Founded
  • 2014

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Fustibal General Information


Provider of a platform for invention validation in the healthcare industry. The company provides a technology platform that helps biotechnology companies to create computational models to design and optimize targeted therapeutics and instantaneous monitoring of disease progression and therapeutic effect, enabling pharmaceutical companies to improve existing chemical and biological pharmaceuticals for efficacy, safety, and unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Primary Office
  • Scottsdale, AZ
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fustibal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Fustibal’s complete valuation and funding history, request access »

Fustibal Executive Team (2)

Name Title Board Seat Contact Info
David Tran Ph.D Co-Founder
Lillian Woung JD Vice President of Pharmaceutical
To view Fustibal’s complete executive team members history, request access »

Fustibal Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MBC BioLabs Accelerator/Incubator 000 0000 000000 0
QB3 Accelerator/Incubator 000 0000 000000 0
To view Fustibal’s complete investors history, request access »